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Abstract: Bone tissue engineering is a rapidly growing field which is currently progressing toward
clinical applications. Effective imaging methods for longitudinal studies are critical to evaluating
the new bone formation and the fate of the scaffolds. Computed tomography (CT) is a prevailing
technique employed to investigate hard tissue scaffolds; however, the CT signal becomes weak
in mainly-water containing materials, which hinders the use of CT for hydrogels-based materials.
Nevertheless, hydrogels such as gelatin methacrylate (GelMA) are widely used for tissue regeneration
due to their optimal biological properties and their ability to induce extracellular matrix formation.
To date, gold nanoparticles (AuNPs) have been suggested as promising contrast agents, due to their
high X-ray attenuation, biocompatibility, and low toxicity. In this study, the effects of different
sizes and concentrations of AuNPs on the mechanical properties and the cytocompatibility of
the bulk GelMA-AuNPs scaffolds were evaluated. Furthermore, the enhancement of CT contrast
with the cytocompatible size and concentration of AuNPs were investigated. 3D printed GelMA
and GelMA-AuNPs scaffolds were obtained and assessed for the osteogenic differentiation of
mesenchymal stem cells (MSC). Lastly, 3D printed GelMA and GelMA-AuNPs scaffolds were scanned
in a bone defect utilizing µCT as the proof of concept that the GelMA-AuNPs are good candidates for
bone tissue engineering with enhanced visibility for µCT imaging.
Keywords: 3D printed gelatin methacrylate hydrogels; gold nanoparticles; µCT imaging; contrast
agent for CT imaging
1. Introduction
Bone tissue engineering (BTE) is a rapidly growing field, with the research being conducted in
various fields, including engineering, pharmaceutics, and medicine [1,2]. The scope of bone tissue
engineering has recently expanded beyond in vitro and animal studies, and is currently progressing
toward clinical applications. Thus, effectual imaging methods for longitudinal studies are critical to
evaluating the outcomes of tissue engineered constructs. For instance, even though histological
techniques provide crucial information, these destructive imaging techniques are incapable of
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providing 3D information, which significantly hinders the use of such conventional methods for in vivo
and preclinical applications [3]. Therefore, an increasing number of recent tissue engineering studies
feature the compatibility of the utilized 3D scaffolds with different advanced imaging modalities [4–7].
Radiography is the second most widely used imaging modality thanks to its good spatial
resolution (50–200 µm), short acquisition time (<10–15 min), and availability. Computed tomography
(CT) is used in the staging and imaging-guided intervention of various diseases, producing 3D
information regarding its non-invasive nature, a high resolution, and deep tissue penetration [8].
Besides its use in diagnostics, CT is an ascendant technique used to evaluate the performance of tissue
implants and tissue engineering scaffolds [9–11]. Furthermore, the use of micro-CT (µCT) enables
researchers to attain voxels with a micrometer spatial resolution, thus it is able to obtain high-resolution
volumetric images in relatively short scan times specifically for hard tissue regeneration and scaffold
degradation [9–13].
In CT imaging, the X-ray attenuation of a material is proportionally related to its atomic number
and density; thereby, the CT contrast is high in mineralized tissues (e.g., bone and teeth), while it
becomes low in mainly-water containing tissues (i.e., soft tissues). For the same reasons, hydrogels, one
of the most prominent materials used in tissue engineering applications, show little or no contrast on
CT images as they mainly consist of water. Enhancement of the CT contrast can be achieved by using
specific contrast agents (CA). To date, gold nanoparticles (AuNPs) have been suggested as promising
CA, as they show high X-ray attenuation (5.16 cm2/g at 100 keV), biocompatibility, low toxicity, high
chemical stability, and narrow size control during synthesis. Moreover, AuNPs have shown the ability
to enhance CT contrast of ceramic-based bone substitutes, as well as to the capability induce osteoblast
differentiation and new bone formation [6,14,15].
Among different hydrogels used for bone tissue engineering applications, gelatin methacrylate
(GelMA) hydrogels are widely used for tissue regeneration due to their optimal biological properties
and their ability to induce extracellular matrix formation [16–18]. Recent insights indicate that
GelMA can specifically induce in vitro osteogenic differentiation and calcium deposition, as well
as endochondral bone formation in vivo, hence supporting its potential use in BTE [19–21]. Besides
desirable biological characteristics, the methacrylate moieties on GelMA’s backbone give rise to a stable
crosslinked hydrogel with rapid permanent crosslinking when exposed to UV light and in the presence
of a suitable photoinitiator. Thus, GelMA hydrogels are suitable materials for different manufacturing
techniques, such as photopatterning, micromolding, and layer-by-layer 3D printing [22].
Layer-by-layer 3D printing is one of the most convenient techniques used to create TE-dedicated
scaffolds with well-distributed and interconnected pores which ensure cell migration, vascular
in-growth, and nutrient diffusion, as well as the removal of waste products [2,23–26]. Furthermore,
printing hydrogels with this technique allows the creation of patient-specific designed scaffolds with
structural complexity, low-cost, and high-efficiency [27].
In this study, we evaluated the effect of different sizes and concentrations of AuNPs on the
mechanical properties and cytocompatibility of the GelMA-AuNPs scaffolds. Furthermore, we have
investigated the enhancement of CT signaling with the cytocompatible size and concentration of
AuNPs. We have printed 3D GelMA and GelMA-AuNPs scaffolds and assessed the effect of the
GelMA-AuNPs on MSC osteogenic differentiation. Lastly, the GelMA and GelMA-AuNPs scaffolds
were inserted into a bone defect and µCT indicated as the proof of concept that the GelMA-AuNPs are
good candidates for bone tissue engineering with enhanced visibility for µCT imaging (Figure 1).
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of the photoinitiator 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (Sigma-Aldrich, 
Poznan, Poland) in PBS at 37 °C. 
To enhance the CT contrast of GelMA-based scaffolds, AuNPs (Sigma-Aldrich, St. Louis, MO, 
USA) stabilized by citrate in 0.1 mM PBS, with different sizes and concentrations, were added to the 
GelMA pre-polymer solution. Specifically, different concentrations of AuNPs were calculated as 0.08 
mM, 0.16 mM, and 0.40 mM. These same concentrations were used for two AuNP sizes, i.e., 40 nm 
and 60 nm. 
2.2. Evaluation of in vitro Cytocompatibility, Mechanical Properties, and µCT Visibility of GelMA and 
GelMA-AuNP Bulk Hydrogels 
To assess the influence of AuNPs on in vitro cytocompatibility, the mechanical properties, and 
µCT visibility of GelMA hydrogel, cylindrical discs of GelMA and GelMA-AuNPs (diameter = 10 
mm, thickness = 1 mm, n = 5) were prepared from pre-polymer solutions. In this study, 25 µL 
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To evaluate the acute cytotoxic effect of AuNP size and concentration, GelMA-AuNP hydrogels 
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2. Materials and Methods
2.1. Preparation of Gelatin Methacrylate (GelMA), GelMA, and GelMA-AuNPs Pre-polymer Solution
GelMA was synthesized as described elsewhere [22]. 10% (w/v) gelatin type A porcine skin
(Sigma-Aldrich, St. Louis, MO, USA) was dissolved in phosphate buffer solution (PBS) at 60 ◦C and
after complete dissolution, 800 µL methacrylic anhydride (Sigma-Aldrich, Poznan, Poland) per gram
of gelatin was added under constant stirring. After the reaction, the mixture was dialyzed against
distilled water using 12–14 kDa cut-off dialysis tubing (Spectra/Por 1 Dialysis Membranes, Spectrum
Labs, Rancho Dominguez, CA, USA) to remove the residual salts and methacrylic anhydride, and the
solution was lyophilized at −80 ◦C.
The pre-polymer solution of GelMA was prepared at a 5% concentration of GelMA and 0.05% of
the photoinitiator 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (Sigma-Aldrich, Poznan,
Poland) in PBS at 37 ◦C.
To enhance the CT contrast of GelMA-based scaffolds, AuNPs (Sigma-Aldrich, St. Louis, MO,
USA) stabilized by citrate in 0.1 mM PBS, with different sizes and concentrations, were added to
the GelMA pre-polymer solution. Specifically, different concentrations of AuNPs were calculated as
0.08 mM, 0.16 mM, and 0.40 mM. These same concentrations were used for two AuNP sizes, i.e., 40 nm
and 60 nm.
2.2. Evaluation of in vitro Cytocompatibility, Mechanical Properties, and µCT Visibility of GelMA and
GelMA-AuNP Bulk Hydrogels
To assess the influence of AuNPs on in vitro cytocompatibility, the mechanical properties, and
µCT visibility of GelMA hydrogel, cylindrical discs of GelMA and GelMA-AuNPs (diameter = 10 mm,
thickness = 1 mm, n = 5) were prepared from pre-polymer solutions. In this study, 25 µL prepolymer
solutions of GelMA and GelMA-AuNPs were pipetted into a PDMS mold and were then exposed to
UV light at 12.5 mW/cm2 UV light (BlueWave® 75 UV Light Curing Spot Lamp, 365 nm, Torrington,
CT) for 60 s for permanent crosslinking.
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To evaluate the acute cytotoxic effect of AuNP size and concentration, GelMA-AuNP hydrogels
(prepared under sterile conditions) were seeded with L929 fibroblasts (mouse C3H/An, ECACC, UK)
and cultured in Dulbecco’s Modified Eagle Medium (DMEM, Gibco, Grand Island, MA, USA), 10%
FBS (EuroClone S.p.A., Pero, Italy), and 100 µg/mL Penicillin-Streptomycin (10,000 U/mL, Gibco,
Bleiswijk, The Netherlands) at 37 ◦C and 5% CO2 for 72 h, according to standard practice UNI EN
ISO 10993-5. Subsequently, the CellTiter Cell Proliferation Assay (MTS, Promega, Fitchburg, WI) was
performed to colorimetrically measure the metabolic activity (FLUOstar Omega UV/Vis spectrometer,
BMG LabTech, Ortenberg, Germany) of the fibroblasts cultured on GelMA (i.e., non-labeled) and the
GelMA-AuNPs (n = 3).
Prior to the mechanical testing, the crosslinking of the hydrogels was evaluated in terms of gel
fraction and swelling from a dry and wet state (Figure S1) [28]. To assess the mechanical properties,
GelMA and GelMA-AuNPs hydrogels were detached from the molds and tested at a rate of 20%
strain/min on a DMA Q800 apparatus (TA Instruments, Warsaw, Poland). The compressive modulus
was determined as the slope of the linear region corresponding to 0–5% strain (n = 5).
Radiopacity assessments of the GelMA-AuNPs hydrogels containing different sizes of AuNPs in
different concentrations were carried out using a Skyscan 1172 (Bruker, Kontich, Belgium) micro CT
(µCT) system with the following settings: 35 kV, 800 µA, pixel size of 10.7 µm. Acquired files were
reconstructed through NRecon (Skyscan, Kontich, Belgium) reconstruction software, while assessment
of the gray value of the hydrogels was performed using CTAnalyser software (version 1.10.1.0, Skyscan,
Kontich, Belgium).
2.3. 3D Printing of GelMA and GelMA-AuNP Scaffolds
GelMA pre-polymer solution was prepared as explained in Section 2.1, sterile filtered (PES
membrane, 0.22 µm), and transferred into the sterile plotting cartridge (Nordson EFD, Westlake,
OH). The plotting cartridge inserted into the printing head of a 3D Bioplotter (Envisiontec, Gladbeck,
Germany) and the GelMA and GelMA-AuNPs solutions were cooled down to 20 ◦C. The pre-polymer
solutions were extruded through a 23G needle with an inner diameter of 330 µm and a length of
3.81 cm (general purpose dispersing tips, Nordson EFD, East Providence, RI, USA) onto the printing
plate, which was cooled down to 4 ◦C. Layer-by-layer printing, a speed of 18 mm/s, a 2.3 bar extrusion
pressure, and a 200 µm layer thickness were used to form 0◦/90◦ oriented strands with a 1.2 mm
distance. CAD files specifying the cylindrical geometry (diameter: 30 mm, thickness: 3 mm) of the
scaffolds were used as the input to produce the physical model for the 3D Bioplotter (EnvisionTech
GmbH, Gladbeck, Germany) and converted into G-code via Visual Machines software (EnvisionTech
GmbH, Gladbeck, Germany) for the printing process. 3D constructs were printed and then exposed to
12.5 mW/cm2 UV light (BlueWave® 75 UV Light Curing Spot Lamp, 365 nm, Torrington, CT, USA) for
60 s for permanent crosslinking.
2.4. In vitro Evaluation of Osteogenic Differentiation of MSCs on GelMA and GelMA-AuNPs
Rat MSCs isolated from six-week-old male Wistar rats (Charles River, Leiden, The Netherlands)
were suspended in growth medium and cultured in an incubator at 37 ◦C and 5% CO2 until they
reached 80% confluence. Afterward, adherent cells were detached by using trypsin/EDTA (0.25%
(w/v) trypsin, 0.02% EDTA, Gibco, Bleiswijk, The Netherlands) counted and seeded onto the scaffolds.
3D printed GelMA (containing 5% (w/v) GelMA) and GelMA-AuNP (containing 5% (w/v) GelMA
and 0.16 mM 60 nm AuNPs) scaffolds were prepared as explained in Section 2.3 and cut into even
scaffolds using 6 mm sterile biopsy punch. Isolated MSCs were seeded at a density of 105 cells/cm2 on
3D printed scaffolds. Scaffolds were cultured in osteogenic medium (α-MEM (Gibco, Carlsbad,
CA, USA), 10% fetal FBS (Gibco, Bleiswijk, The Netherlands), 50 mg/mL ascorbic acid (Sigma
Aldrich, Poznan, Poland), 10 mM β-glycerolphosphate (Sigma Aldrich, Poznan, Poland), 10−8 M
dexamethasone (Sigma Aldrich, Poznan, Poland), and 50 mg/mL gentamycin (Gibco, Bleiswijk, The
Netherlands) at 37 ◦C and 5% CO2 over 28 days. At different time points (i.e., day 7, day 14, day 21,
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and day 28), the scaffolds (n = 5) were washed in PBS and cells were lysed through freeze-thaw cycles.
Supernatants were collected for DNA–Alkaline Phosphatase (AP) quantification and scaffolds were
further incubated overnight in 1 mL of 0.5 M acetic acid solution to dissolve calcium (Ca) ions for Ca
quantification. The QuantiFluorVR dsDNA system (Promega Corporation, Madison, WI, USA) was
used to measure the total amount of DNA, which was determined fluorometrically at an excitation
wavelength of 485 nm and an emission wavelength of 530 nm. The AP activity was measured
colorimetrically by using p-nitrophenyl phosphate as the substrate. The absorbance was measured
at 405 nm using a spectrophotometer. AP activity was directly converted from the absorbance and
then correlated according to the DNA content of the scaffolds. The calcium content of the scaffolds
was then determined using lysates in acetic acid and the ortho-cresolphthalein complexone (OCPC
method). The absorbance was measured at 570 nm.
2.5. In Vitro Imaging of the GelMA and GelMA-AuNP Scaffolds in µCT
3D printed GelMA and GelMA-AuNPs scaffolds were cut into 3 mm scaffolds using a biopsy
punch and inserted into a rat condyle bone defect (3 mm diameter). Radiopacity assessments were
carried out using a Skyscan 1174 (Bruker, Kontich, Belgium) micro CT (µCT) system with the following
settings: 50 kV, 800 µA, pixel size of 10.7 µm. Acquired files were reconstructed through NRecon
(Skyscan, Kontich, Belgium) reconstruction software, while assessment of the gray value of the
hydrogels was performed using CTAnalyser software (version 1.10.1.0, Skyscan, Kontich, Belgium).
2.6. Statistical Method
Samples were tested in triplicate or quintuplicate, and data are reported as the mean value ±
standard deviation. Statistical analysis was performed using ANOVA followed by Sidak’s multiple
comparison test using GraphPad Prism 5.00 software (La Jolla, CA, USA). Difference was considered
statistically significant if p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***).
3. Results
3.1. Characterization of GelMA-AuNPs Bulk Hydrogel
To enhance CT contrast of GelMA-based scaffolds, AuNPs, with different sizes and concentrations,
were added to GelMA pre-polymer solution. Cellular metabolic activity of the L929 cell line
significantly decreased for AuNP concentrations at 0.4 mM, for both 40 nm and 60 nm sized
nanoparticles (Figure 2a). Therefore, mechanical testing and µCT scanning on GelMA-AuNPs was
only subsequently performed in the cytocompatible concentration range (Figure 2b–c).
The results indicated that the addition of both 40 nm and 60 nm AuNPs did not significantly
affect the compressive modulus of the GelMA hydrogels (Figure 2b). Afterwards, both GelMA and
GelMA-AuNP hydrogels were scanned and compared regarding the changes in X-Ray attenuation
(Figure 2c). The histogram of the gray values distribution showed a shift in the gray values for the
hydrogel compositions labeled with the AuNPs. Particularly, a distinctive shift in the gray value
and a sharper curve with an increased frequency were attained when 60 nm AuNPs were used
with a concentration of 0.16 mM. Therefore, the GelMA-AuNPs formulation containing 0.16 mM
60 nm AuNPs was selected as showing the best performance in terms of mechanical properties,
cytocompatibility, and enhanced radiopacity. Such GelMA-AuNPs hydrogel was used to prepare the
GelMA-AuNPs scaffold for the osteogenic differentiation of MSCs.
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effect of AuNP size and concentration on radiopacity of GelMA-AuNP hydrogels. Blue marks the 
composition that showed the best X-ray attenuation value. 
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and GelMA-AuNP solutions were cooled down to 20 °C and extruded onto a printing plate at 4 °C. 
The 3D constructs were printed with a printing speed of 18 mm/s, 2.3 bar extrusion pressure, and 200 
µm layer thickness to ensure that 0°/90° oriented strands with a 1.2 mm distance were created (Figure 
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3.2. 3D Printing of GelMA and GelMA-AuNP Scaffolds
During the 3D printing process of hydrogels, it is crucial to attain stability of the 3D construct
through permanent or temporary crosslinking methods. GelMA is a derivative of gelatin and shows
similar thermoresponsive characteristics to gelatin hydrogels. Utilizing this characteristic, the GelMA
and GelMA-AuNP solutions were cooled down to 20 ◦C and extruded onto a printing plate at 4 ◦C.
The 3D constructs were printed with a printing speed of 18 mm/s, 2.3 bar extrusion pressure, and
200 µm layer thickness to ensure that 0◦/90◦ oriented strands with a 1.2 mm distance were created
(Figure 3).
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3.3. In Vitro Evaluation of steogenic ifferentiation of SCs on Gel A and Gel A-Au Ps
content, alkaline phosphatase activity, and Ca deposition on el and el - u P
scaffolds ere evaluated for 28 days (Figure 4). P is an early osteogenic arker and in charge of
ineralization of the extracellular atrix (EC ). Thus, e quantified the P activity of SCs to
evaluate their osteogenic differentiation. s seen in Figure 4a, e did not observe any significant
difference in the DNA content on GelMA scaffolds compared to GelMA-AuNP scaffolds over 28 days.
On day 14, we attained a significant decrease in DNA content for both GelMA and GelMA-AuNP
scaffolds and the decrease continued gradually over 28 days. We showed the AP activity of MSCs in
Figure 2b, where no significant difference was observed between GelMA and GelMA-AuNP scaffolds,
regardless of time points. We obtained significantly increased AP activity on day 14 for both GelMA
and Gel -AuNP scaffolds and after this, a decrease by day 21. For both hydrogel compositions,
the calcium deposition on scaffolds began on day 14 and a significant increase in Ca accumulation
was observed on the structures by day 21 (Figure 4c). The increased AP activity with the outset of Ca
deposition on scaffolds on day 14 and a gradual increase in the Ca accumulation indicated that the
MSCs were dedicated to osteogenic differentiation.
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i r 4. Colorimetric quantification of DNA content (a), alkaline phosphatase activity (b), and calcium
deposition (c) through 28 days in vitro culture of MSCs over 28 days on GelMA and GelMA-AuNP
scaffolds (n = 5, *: p < 0.05, **: p < 0.01).
3.4. In Vitro Imaging of the 3D Printed GelMA and GelMA-AuNP Scaffolds in µCT
3D printed GelMA and GelMA-AuNPs were inserted into a condyle defect and scanned utilizing
µCT. The acquired images were reconstructed; transversal (a,c,e) and coronal (b,d,f) cross-sections
are qualitatively represented in Figure 5. It can be seen that visualization of 3D micro architecture
was enhanced through encapsulation of the AuNPs. Furthermore, the histogram of the gray values
distribution shows a distinctive shift in the gray value for 3D printed Gel A-AuNP scaffolds.
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and GelMA-AuNP hydrogels to the bone tissue.
. i i
sed hydrogels can serve as 3D model ystems for different tissue e gineering
t eir che ical, biological, and mechanical properties can be easily adjusted for the
t rest [29]. Our recent study showed the osteogenic differentiati n of MSC, the
s calcification through the GelMA hydrogels, and suitability for BTE applications [20].
fter testing hydrogels containing different concentrations of GelMA, the composition with a 5% (w/v)
ratio showed higher MSC attachment. Similarly, more homogeneous and significantly higher calcium
deposition was also observed when 5% GelMA hydrogels were used. These results supported our
choice of GelMA as a suitable material for BTE and also indicated the ideal concentration that needed
to be used in further studies (i.e., 5% w/v). Even though the bulk GelMA hydrogels are suitable
candidates to be used in bone tissue engineering, bone is a vascular tissue, whereby the integration of
microchannels into GelMA hydrogels can further stimulate vascular network formation and increase
the perfusion through the hydrogel [30]. Thanks to GelMA’s thermoresponsive characteristic, GelMA
becomes a weak gel below its sol-gel transition temperature, which can be easily extruded through a
nozzle for 3D printing purposes.
CT imaging gives highly substantial information regarding highly mineralized tissues (e.g.,
bone and teeth); however, the signals attained through high water-containing tissues or hydrogels
are significantly low. Thus, even though hydrogels have been used for BTE applications, CT was
only used to image the newly formed bone. [31–33] To overcome the challenge of imaging GelMA
hydrogel via CT, it was hypothesized that the combination of GelMA with specific CA would improve
the overall X-ray attenuation of the scaffold. Similarly, in previous studies, different iodinated
hydrogel formulations were studied in the embolization of blood vessel applications, nucleus pulposus
replacements, and as fiducial markers in gynecologic-cancer patients [34–36]. Hertig et. al. [37]
suggested iodixanol combin d fibrin hydrog ls for endodontic applications. Their ex vivo preliminary
experiments in human teeth showed that the radiopacity of the fibrin hydrogel was only sufficient for
correct localization of th implant. Nonetheless, it was indicated that char cteristics of hydrogels
dramatically changed due to the addition of the iod x nol CA. [37] In t is tudy, it was cruc al to
preserve the physicochemi al properties of the scaffolds and t eir cytocompatible characteristics.
Thus, among differ nt CAs, AuNPs have been utilized as a promising candidate due to their high
X-ray attenuation, depending on their size and concentration [38]. The cytocompatibility of the gold
nanoparticles has been questioned and evaluated in much previous research, as multiple studies have
reported damaging effects of AuNPs regarding size and concentration. The cytotoxic effects of AuNPs
can be observed as delays in doubling time, inhibition of proliferation, or increased apoptosis [38–41].
Therefore, the safety assessment and theranostic efficiency of AuNPs are crucially important for
their applications in tissue engineering. It has been previously reported that the cytocompatibility
of AuNPs increases with increased particle size. Nevertheless, Soenen et al. recently reported that
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toxic effects exerted by AuNPs are directly linked to their cellular uptake levels, so the influence of
size may not be so straightforward, as well as the concentration [42]. Thus, firstly, we have evaluated
the cytocompatibility in terms of the concentration and size of the AuNPs. The high concentration
of AuNPs encapsulated in the GelMA scaffolds reduced the metabolic activity; consequently, the
groups carrying 0.4 mM AuNPs were excluded from the study. In the range where AuNPs were not
significantly affecting the metabolic activity of the L929s, the effectiveness of AuNPs was investigated
as CA. AuNPs, besides their high X-Ray attenuation coefficient, have also been described to play
a crucial role in vitro in the osteogenic differentiation of mesenchymal stem cells through the P38
mitogen-activated protein kinase pathway (MAPK) [14] and induce more bone formation (i.e., >12%)
when compared to GelMA without AuNPs. [15] In line with the previous studies, here it was reported
the AuNPs encapsulated in GelMA scaffolds did not hinder osteogenic differentiation of MSCs, and
increased AP activity and calcification through the scaffolds were attained in GelMA-AuNP scaffolds
without any significant difference compared to the GelMA scaffolds.
The AuNP sizes and concentrations used in this study were sufficient to increase the attenuation
between GelMA hydrogel and the hard tissue mimicking constructs. Thanks to the apparent
difference between bone and GelMA-AuNPs, the scaffold was clearly distinguishable through the
construct; besides, the higher attenuation of GelMA-AuNPs compared to GelMA scaffolds can ensure
better structural information regarding CT analysis and reconstruction. Most likely, higher AuNPs
concentrations (> 0.4 mM) may give better CT attenuation; however, this may also dramatically affect
the mechanical and biological properties of the GelMA.
5. Conclusions
With the recent progress in biomedical research, the monitoring of TE constructs possesses
vital importance for translational research. Thus, the design of new TE scaffolds should not only
address the need for biomaterials with optimal biological properties, but also focus on the imaging
strategies required to follow its fate once implanted in vivo. In this study, a 3D printed GelMA-AuNPs
scaffold with a high porosity and interconnectivity was designed. A cytocompatible AuNP size
and concentration were evaluated to ensure enhancement in X-Ray attenuation without changing
the physicochemical characteristics of the 3D printed GelMA scaffolds. These scaffolds showed
good cytocompatibility for BTE application and evident osteogenic features. Moreover, 3D printed
GelMA-AuNP scaffolds ensured better structural information regarding CT analysis and reconstruction.
In conclusion, as the proof of concept, 3D printed GelMA-AuNPs scaffolds are good candidates for
use in bone tissue engineering with enhanced visibility for µCT imaging.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4360/11/2/367/s1.
Author Contributions: Data curation, N.C. and S.M.; Investigation, N.C. and S.M; Methodology, N.C.; Resources,
S.M; Supervision, X.F.W. and W.S.; Writing–original draft, N.C.; Writing–review & editing, N.C., S.M., X.F.W.,
and W.S.
Funding: This research was funded by the People Programme (Marie Curie Actions) of the European Union’s
Seventh Framework Programme FP7/2007-2013/under REA grants agreement No. 607868 (iTERM) and the
National Centre for Research and Development in the frame of the iTE project (306888 POL).
Acknowledgments: The research leading to these results has received funding from the People Programme
(Marie Curie Actions) of the European Union’s Seventh Framework Programme FP7/2007-2013/under REA
grants agreement No. 607868 (iTERM) and the National Centre for Research and Development in the frame of the
iTE project (306888 POL).
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design of the
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to
publish the results.
Polymers 2019, 11, 367 11 of 13
References
1. Chen, B.-Q.; Kankala, R.K.; Chen, A.-Z.; Yang, D.-Z.; Cheng, X.-X.; Jiang, N.-N.; Zhu, K.; Wang, S.-B.
Investigation of silk fibroin nanoparticle-decorated poly (l-lactic acid) composite scaffolds for osteoblast
growth and differentiation. Int. J. Nanomed. 2017, 12, 1877. [CrossRef]
2. Kankala, R.; Lu, F.-J.; Liu, C.-G.; Zhang, S.-S.; Chen, A.-Z.; Wang, S.-B. Effect of icariin on engineered
3d-printed porous scaffolds for cartilage repair. Materials. 2018, 11, 1390. [CrossRef]
3. Nam, S.Y.; Ricles, L.M.; Suggs, L.J.; Emelianov, S.Y. Imaging Strategies for Tissue Engineering Applications.
Tissue Eng. Part B Rev. 2015, 21, 88–103. [CrossRef]
4. Janke, H.P.; Güvener, N.; Dou, W.; Tiemessen, D.M.; YantiSetiasti, A.; Cremers, J.G.O.; Borm, P.J.A.;
Feitz, W.F.J.; Heerschap, A.; Kiessling, F. Labeling of Collagen Type I Templates with a Naturally Derived
Contrast Agent for Noninvasive MR Imaging in Soft Tissue Engineering. Adv. Healthc. Mater. 2018, 7,
1800605. [CrossRef]
5. Mastrogiacomo, S.; Güvener, N.; Dou, W.; Alghamdi, H.S.; Camargo, W.A.; Cremers, J.G.O.; Borm, P.J.A.;
Heerschap, A.; Oosterwijk, E.; Jansen, J.A. A theranostic dental pulp capping agent with improved MRI and
CT contrast and biological properties. Acta Biomater. 2017, 62, 340–351. [CrossRef]
6. Mastrogiacomo, S.; Dou, W.; Koshkina, O.; Boerman, O.C.; Jansen, J.A.; Heerschap, A.; Srinivas, M.;
Walboomers, X.F. Perfluorocarbon/Gold Loading for Noninvasive in Vivo Assessment of Bone Fillers
Using (19)F Magnetic Resonance Imaging and Computed Tomography. ACS Appl. Mater. Interfaces 2017.
[CrossRef]
7. Kankala, R.K.; Zhu, K.; Sun, X.-N.; Liu, C.-G.; Wang, S.-B.; Chen, A.-Z. Cardiac tissue engineering on the
nanoscale. ACS Biomater. Sci. Eng. 2018, 4, 800–818. [CrossRef]
8. Carlos, J.; Vega, D. La; Häfeli, U.O. Utilization of nanoparticles as X-ray contrast agents for diagnostic
imaging applications. Contrast Media Mol. Imaging. 2015. [CrossRef]
9. Rumin´ski, S.; Ostrowska, B.; Jaroszewicz, J.; Skirecki, T.; Włodarski, K.; S´wie˛szkowski, W.;
Lewandowska-Szumieł, M. Three-dimensional printed polycaprolactone-based scaffolds provide an
advantageous environment for osteogenic differentiation of human adipose-derived stem cells. J. Tissue Eng.
Regen. Med. 2018, 12, e473–e485. [CrossRef]
10. Cuijpers, V.M.J.I.; Alghamdi, H.S.; Van Dijk, N.W.M.; Jaroszewicz, J.; Walboomers, X.F.; Jansen, J.A.
Osteogenesis around CaP-coated titanium implants visualized using 3D histology and micro-computed
tomography. J. Biomed. Mater. Res. Part A 2015, 103, 3463–3473. [CrossRef]
11. Costantini, M.; Testa, S.; Mozetic, P.; Barbetta, A.; Fuoco, C.; Fornetti, E.; Tamiro, F.; Bernardini, S.;
Jaroszewicz, J.; Swieszkowski, W.; et al. Microfluidic-enhanced 3D bioprinting of aligned myoblast-laden
hydrogels leads to functionally organized myofibers in vitro and in vivo. Biomaterials 2017, 131, 98–110.
[CrossRef]
12. Jones, A.C.; Arns, C.H.; Sheppard, A.P.; Hutmacher, D.W.; Milthorpe, B.K.; Knackstedt, M.A. Assessment of
bone ingrowth into porous biomaterials using MICRO-CT. Biomaterials 2007, 28, 2491–2504. [CrossRef]
13. Ho, S.T.; Hutmacher, D.W. A comparison of micro CT with other techniques used in the characterization of
scaffolds. Biomaterials 2006, 27, 1362–1376. [CrossRef]
14. Yi, C.; Liu, D.; Fong, C.-C.; Zhang, J.; Yang, M. Gold nanoparticles promote osteogenic differentiation of
mesenchymal stem cells through p38 MAPK pathway. ACS Nano 2010, 4, 6439–6448. [CrossRef]
15. Heo, D.N.; Ko, W.-K.; Bae, M.S.; Lee, J.B.; Lee, D.-W.; Byun, W.; Lee, C.H.; Kim, E.-C.; Jung, B.-Y.; Kwon, I.K.
Enhanced bone regeneration with a gold nanoparticle–hydrogel complex. J. Mater. Chem. B 2014, 2, 1584.
[CrossRef]
16. Schuurman, W.; Levett, P.A.; Pot, M.W.; van Weeren, P.R.; Dhert, W.J.A.; Hutmacher, D.W.; Melchels, F.P.W.;
Klein, T.J.; Malda, J. Gelatin-methacrylamide hydrogels as potential biomaterials for fabrication of
tissue-engineered cartilage constructs. Macromol. Biosci. 2013, 13, 551–561. [CrossRef]
17. Levett, P.A.; Melchels, F.P.W.; Schrobback, K.; Hutmacher, D.W.; Malda, J.; Klein, T.J. A biomimetic
extracellular matrix for cartilage tissue engineering centered on photocurable gelatin, hyaluronic acid
and chondroitin sulfate. Acta Biomater. 2014, 10, 214–223. [CrossRef]
18. Rinoldi, C.; Costantini, M.; Kijen´ska-Gawron´ska, E.; Testa, S.; Fornetti, E.; Heljak, M.; C´wiklin´ska, M.;
Buda, R.; Baldi, J.; Cannata, S. Tendon Tissue Engineering: Effects of Mechanical and Biochemical Stimulation
on Stem Cell Alignment on Cell-Laden Hydrogel Yarns. Adv. Healthc. Mater. 2019, 1801218. [CrossRef]
Polymers 2019, 11, 367 12 of 13
19. Kang, H.; Shih, Y.R.V.; Hwang, Y.; Wen, C.; Rao, V.; Seo, T.; Varghese, S. Mineralized gelatin
methacrylate-based matrices induce osteogenic differentiation of human induced pluripotent stem cells.
Acta Biomater. 2014, 10, 4961–4970. [CrossRef]
20. Celikkin, N.; Mastrogiacomo, S.; Jaroszewicz, J.; Walboomers, X.F.; Swieszkowski, W. Gelatin methacrylate
scaffold for bone tissue engineering: The influence of polymer concentration. J. Biomed. Mater. Res. Part A
2017. [CrossRef]
21. Visser, J.; Gawlitta, D.; Benders, K.E.M.; Toma, S.M.H.; Pouran, B.; van Weeren, P.R.; Dhert, W.J.A.; Malda, J.
Endochondral bone formation in gelatin methacrylamide hydrogel with embedded cartilage-derived matrix
particles. Biomaterials 2015, 37, 174–182. [CrossRef]
22. Yue, K.; Santiago, G.T.; Tamayol, A.; Annabi, N.; Khademhosseini, A.; Hospital, W.; Arabia, S.; Trujillo-De
Santiago, G.; Alvarez, M.M.; Tamayol, A.; et al. Synthesis, properties, and biomedical applications of gelatin
methacryloyl (GelMA) hydrogels. Biomaterials 2015, 73, 254–271. [CrossRef]
23. Wang, H.; Zhou, L.; Liao, J.; Tan, Y.; Ouyang, K.; Ning, C.; Ni, G.; Tan, G. Cell-laden photocrosslinked
GelMA-DexMA copolymer hydrogels with tunable mechanical properties for tissue engineering. J. Mater.
Sci. Mater. Med. 2014, 25, 2173–2183. [CrossRef]
24. Murphy, C.M.; Haugh, M.G. The effect of mean pore size on cell attachment, proliferation and migration in
collagen glycosaminoglycan scaffolds for tissue engineering. Biomaterials 2010, 31, 461–466. [CrossRef]
25. Kankala, R.K.; Zhu, K.; Li, J.; Wang, C.-S.; Wang, S.-B.; Chen, A.-Z. Fabrication of arbitrary 3D components
in cardiac surgery: From macro-, micro-to nanoscale. Biofabrication 2017, 9, 32002. [CrossRef]
26. Kankala, R.; Xu, X.-M.; Liu, C.-G.; Chen, A.-Z.; Wang, S.-B. 3D-printing of microfibrous porous scaffolds
based on hybrid approaches for bone tissue engineering. Polymers. 2018, 10, 807. [CrossRef]
27. Ji, S.; Guvendiren, M. Recent Advances in Bioink Design for 3D Bioprinting of Tissues and Organs.
Front. Bioeng. Biotechnol. 2017, 5, 23. [CrossRef]
28. Negrini, N.C.; Bonnetier, M.; Giatsidis, G.; Orgill, D.P.; Farè, S.; Marelli, B. Tissue-mimicking gelatin scaffolds
by alginate sacrificial templates for adipose tissue engineering. Acta Biomater. 2019.
29. Loessner, D.; Meinert, C.; Kaemmerer, E.; Martine, L.C.; Yue, K.; Levett, P. a; Klein, T.J.; Melchels, F.P.W.;
Khademhosseini, A.; Hutmacher, D.W. Functionalization, preparation and use of cell-laden gelatin
methacryloyl-based hydrogels as modular tissue culture platforms. Nat. Protoc. 2016, 11, 727–746. [CrossRef]
30. Nichol, J.W.; Koshy, S.T.; Bae, H.; Hwang, C.M.; Yamanlar, S.; Khademhosseini, A. Cell-laden
microengineered gelatin methacrylate hydrogels. Biomaterials 2010, 31, 5536–5544. [CrossRef]
31. Moreau, D.; Villain, A.; Bachy, M.; Proudhon, H.; Ku, D.N.; Hannouche, D.; Petite, H.; Corté, L. In vivo
evaluation of the bone integration of coated poly(vinyl-alcohol) hydrogel fiber implants. J. Mater. Sci.
Mater. Med. 2017, 28. [CrossRef]
32. He, B.; Ou, Y.; Chen, S.; Zhao, W.; Zhou, A.; Zhao, J.; Li, H.; Jiang, D.; Zhu, Y. Designer bFGF-incorporated
D-form self-assembly peptide nanofiber scaffolds to promote bone repair. Mater. Sci. Eng. C 2017, 74, 451–458.
[CrossRef]
33. Lohmann, P.; Willuweit, A.; Neffe, A.T.; Geisler, S.; Gebauer, T.P.; Beer, S.; Coenen, H.H.; Fischer, H.;
Hermanns-Sachweh, B.; Lendlein, A.; et al. Bone regeneration induced by a 3D architectured hydrogel in a
rat critical-size calvarial defect. Biomaterials 2017, 113, 158–169. [CrossRef]
34. Bair, R.J.; Bair, E.; Viswanathan, A.N. A radiopaque polymer hydrogel used as a fiducial marker in
gynecologic-cancer patients receiving brachytherapy. Brachytherapy 2015, 14, 876–880. [CrossRef]
35. Fatimi, A.; Zehtabi, F.; Lerouge, S. Optimization and characterization of injectable chitosan-iodixanol- based
hydrogels for the embolization of blood vessels. Soc. Biomater. 2015, 1–12. [CrossRef]
36. Boelen, E.J.H.; Koole, L.H.; van Rhijn, L.; van Hooy-Corstjens, C.S.J. Towards a Functional Radiopaque
Hydrogel for Nucleus Pulposus Replacement. J. Biomed. Mater. Res. Part B Appl. Biomater. 2007, 83, 440–450.
[CrossRef]
37. Hertig, G.; Zehnder, M.; Woloszyk, A.; Mitsiadis, T.A.; Ivica, A.; Weber, F.E. Iodixanol as a contrast agent in a
fibrin hydrogel for endodontic applications. Front. Physiol. 2017, 8, 1–6. [CrossRef]
38. Pan, Y.; Neuss, S.; Leifert, A.; Fischler, M.; Wen, F.; Simon, U.; Schmid, G.; Brandau, W.; Jahnen-Dechent, W.
Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3, 1941–1949. [CrossRef]
39. Mironava, T.; Hadjiargyrou, M.; Simon, M.; Jurukovski, V.; Rafailovich, M.H. Gold nanoparticles cellular
toxicity and recovery: Effect of size, concentration and exposure time. Nanotoxicology 2010, 4, 120–137.
[CrossRef]
Polymers 2019, 11, 367 13 of 13
40. Pernodet, N.; Fang, X.; Sun, Y.; Bakhtina, A.; Ramakrishnan, A.; Sokolov, J.; Ulman, A.; Rafailovich, M.
Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. Small 2006, 2, 766–773. [CrossRef]
41. Chang, M.; Shiau, A.; Chen, Y.; Chang, C.; Chen, H.H.; Wu, C. Increased apoptotic potential and
dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on
tumor-bearing mice. Cancer Sci. 2008, 99, 1479–1484. [CrossRef]
42. Soenen, S.J.; Rivera-Gil, P.; Montenegro, J.-M.; Parak, W.J.; De Smedt, S.C.; Braeckmans, K. Cellular toxicity of
inorganic nanoparticles: Common aspects and guidelines for improved nanotoxicity evaluation. Nano Today
2011, 6, 446–465. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
